Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain

Vaccine

Volumn 30, Issue 45, 2012, Pages 6427-6435

  Hung, Ivan F N ^a,b   Levin, Yotam ^c   To, Kelvin K W ^a   Chan, Kwok Hung ^a   Zhang, Anna Jinxia ^a   Li, Patrick ^a   Li, Clara ^a   Xu, Ting ^a   Wong, Tin Yan ^a   Yuen, Kwok Yung ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c NANOPASS TECHNOLOGIES LTD   (Israel)

Author keywords

2009 H1N1; Immunogenicity; Influenza; Intradermal; Vaccine

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; TRIVALENT INFLUENZA VACCINE; UNCLASSIFIED DRUG;

AGED; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; DEVICES; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG SAFETY; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INJECTION SITE ERYTHEMA; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

AGED; ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; MALE; NEUTRALIZATION TESTS; PROSPECTIVE STUDIES; VACCINATION;

EID: 84866505857     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.014     Document Type: Article

References (32)

1. Fleming D.M., Elliot A.J. The impact of influenza on the health and health care utilisation of elderly people. Vaccine 2005, 23(Suppl. 1):S1-S9.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. J Am Med Assoc 2004, 292:1333-1340.
3. Warren-Gash C., Smeeth L., Hayward A.C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009, 9:601-610.
4. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348:1322-1332.
5. Hung I.F., Leung A.Y., Chu D.W., Leung D., Cheung T., Chan C.K., et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010, 51:1007-1016.
6. To K.K., Hung I.F., Li I.W., Lee K.L., Koo C.K., Yan W.W., et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010, 50:850-859.
7. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007, 357:1373-1381.
8. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995, 123:518-527.
9. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
10. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. J Am Med Assoc 2003, 289:179-186.
11. Kovaiou R.D., Herndler-Brandstetter D., Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med 2007, 9:1-17.
12. Myers C.A., Faix D.J., Blair P.J. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine. Clin Infect Dis 2011, 53:207-208.
13. Hung I.F., Levin Y., To K.K. Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination. Vaccine 2012, 30:2707-2708.
14. Van Damme P., Oosterhuis-Kafeja F., Van der Wielen M., Almagor Y., Sharon O., Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009, 27:454-459.
15. Leroux-Roels I., Vets E., Freese R., Seiberling M., Weber F., Salamand C., et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 2008, 26:6614-6619.
16. Beran J., Ambrozaitis A., Laiskonis A., Mickuviene N., Bacart P., Calozet Y., et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 2009, 7:13.
17. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004, 351:2286-2294.
18. Hung I.F., To K.K., Lee C.K., Lin C.K., Chan J.F., Tse H., et al. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis 2010, 51:274-279.
19. Chan K.H., To K.K., Hung I.F., Zhang A.J., Chan J.F., Cheng V.C., et al. Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza. Clin Vaccine Immunol 2011, 18:867-873.
20. Campbell J.D., Chambers C.V., Brady R.C., Caldwell M.C., Bennett N.L., Fourneau M.A., et al. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: randomized controlled trial. Hum Vaccine 2011, 7:81-88.
21. (accessed 30.04.12). http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatory%20Information/Guidances/Vaccines/ucm074794.htm.
22. Uno S., Kimachi K., Kei J., Miyazaki K., Oohama A., Nishimura T., et al. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: randomized controlled trial. Microbiol Immunol 2011, 55:783-789.
23. Wu J., Zhong X., Li C.K., Zhou J.F., Lu M., Huang K.Y., et al. Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 2011, 29:1009-1016.
24. ® 9μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther 2011, 28:640-649.
25. Arnou R., Frank M., Hagel T., Prébet A. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany. Adv Ther 2011, 28:555-565.
26. Bellei N.C., Carraro E., Castelo A., Granato C.F. Risk factors for poor immune response to influenza vaccination in elderly people. Braz J Infect Dis 2006, 10:269-273.
27. Song J.Y., Cheong H.J., Hwang I.S., Choi W.S., Jo Y.M., Park D.W., et al. Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine 2010, 28:3929-3935.
28. Skowronski D.M., Hottes T.S., Janjua N.Z., Purych D., Sabaiduc S., Chan T., et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 2010, 182:1851-1856.
29. Pearton M., Kang S.M., Song J.M., Anstey A.V., Ivory M., Compans R.W., et al. Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS ONE 2010, 5:e12410.
30. ®) administered by intradermal and intramuscular route in healthy adults. Vaccine 2011, 29:5666-5674.
31. Esposito S., Daleno C., Picciolli I., Tagliaferri L., Scala A., Prunotto G., et al. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine 2011, 29:7606-7610.
32. Morelon E., Pouteil Noble C., Daoud S., Cahen R., Goujon-Henry C., Weber F., et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 2010, 28:6885-6890.